OGN:NYSE
Organon & Co
USD 13,90
arrow_downward
-0,04%(-0,0050) 1D
USD 13,90
0,00% (0,00)
bedtimeAfter hours
Closed: 17 Nov., 16:00:04 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
USD 13,90
High
USD 13,91
Low
USD 13,89
Mkt. cap
3,65 mjd
Avg. vol.
2,55 m
Volume
0,00
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,08
52-wk high
USD 13,91
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
Open
USD 13,90
High
USD 13,91
Low
USD 13,89
Mkt. cap
3,65 mjd
Avg. vol.
2,55 m
Volume
0,00
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,08
52-wk high
USD 13,91
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
News stories
From web sources and news partners
TradingView
·
1 uur gelede
SPX: S&P 500 Futures Edge Higher After Four-Day Slide, Nvidia Earnings Buoy Tech Stocks
BigGo Finance
·
10 uur gelede
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
Benzinga
·
2 uur gelede
Stock Market: Will S&P 500 Open Up or Down Today?
Fox Business
·
13 uur gelede
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 k
Founded1923
HeadquartersJersey City, New Jersey, Verenigde State van Amerika
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com